No Apparent Remedy in Lattice Semiconductor/Canyon Bridge Deal

With additional reporting by Sarah Cohen – Lattice Semiconductor and Canyon Bridge jointly withdrew and refiled their voluntary notice to the Committee on Foreign Investment infeatured

Congress Plans Broader Role for Security Reviews

In a rare bipartisan review, members of Congress are studying proposals that would expand the reach of the Committee on Foreign Investment in the United States that would likely add representation from additional federal agencies and allow CFIUS to probe deeper into M&A involving entities owned or partially owned by foreign governments.featured

CFIUS Pull-and-Refile Perpetuates Doubts on Lattice/Canyon Bridge Deal

Lattice Semiconductor’s pulling and refiling of its submission to the Committee on Foreign Investment in the United States of Lattice’s announced acquisition by China-backed buyoutfeatured

China Oceanwide Committed to Putting More Money into Genworth

Regulators in New York became favorably disposed to China Oceanwide’s acquisition of Genworth after the buyer committed to significantly increase its financial commitment, accordingfeatured

Stillwater Mining/Sibanye Review Extended by CFIUS

With additional reporting by Diane Alter and Valeria Camerino – The review of the proposed acquisition of Stillwater Mining, the US’s only producer of platinum and palladium,featured

Experts See MoneyGram/Ant Financial Deal Clearing CFIUS with Heavy Scrutiny

A former policy adviser to the National Security Council told CTFN that the acquisition of MoneyGram by Ant Financial raises critical concerns around data privacy, data protection, andfeatured

Election Not Grounds for CFIUS Re-Examination of Syngenta/ChemChina

With additional reporting by Sarah Cohen and Diane Alter – The Committee on Foreign Investment in the United States cannot re-examine ChemChina’s $43 billion purchase of Syngenta of Switzerland merely because Donald Trump, a Republican, willfeatured

Genworth-China Oceanwide Deal in Doubt

The likelihood that regulators will approve China Oceanwide Holdings’ $2.7 billion, or $5.43 per share, acquisition of Genworth Financial is slim, several attorneys told CTFN. “I don’t see this deal happening no way and no how,” an insurance regulatory attorney close to Genworth said. “This is evenfeatured

Regulators Could Take a Year to Decide Renesas/Intersil Remedies

If remedies are necessary to safeguard Intersil’s facility in Palm Bay, Florida, where it manufactures chips for defense purposes, regulators including the Committee on Foreign Investment in the United States and the Defense Security Service are likely to take between three months to a year to decide the site’s fate, two sector lawyers told CTFN. … Read Morefeatured

Ingram Micro’s Federal Business May Not Require Sale

In the event that the Committee on Foreign Investment in the United States demands that Ingram Micro divest its federal business to proceed with its takeout by Tianjin Tianhai/HNA Group, the remedy might be as simple as terminating contracts, and need not require the sale of a business, suggested sources in the distribution, legal, and … Read Morefeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.